Steven B Chinn Selected Research

Steven B Chinn Research Topics

Disease

23	Neoplasms (Cancer) 11/2023 - 02/2011
23	Squamous Cell Carcinoma of Head and Neck 11/2023 - 10/2006
8	Head and Neck Neoplasms (Head and Neck Cancer) 11/2023 - 01/2020
6	Oropharyngeal Neoplasms 04/2024 - 01/2017
5	COVID-19 11/2022 - 01/2020
4	Wounds and Injuries (Trauma) 05/2024 - 05/2018
4	Fistula 05/2024 - 05/2018
4	Laryngeal Neoplasms (Laryngeal Cancer) 03/2022 - 02/2014
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 02/2011
3	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2012
2	Hypothyroidism 05/2024 - 05/2018
1	Airway Obstruction (Choking) 11/2023
1	Ischemia 11/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2023
1	Cranial Nerve Injuries 01/2023
1	Surgical Wound 01/2023
1	Bites and Stings (Sting) 01/2023
1	Death (Near-Death Experience) 01/2023
1	Infections 11/2022
1	Cellulitis 10/2021
1	Abscess 10/2021
1	Malocclusion (Crossbite) 10/2021
1	Thrombosis (Thrombus) 10/2021
1	Seroma 10/2021
1	Hematoma 10/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021
1	Critical Illness (Critically Ill) 07/2021
1	Respiratory Insufficiency (Respiratory Failure) 07/2021
1	Disease Progression 07/2021
1	Hemorrhage 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Hypocalcemia 08/2019
1	Fanconi Anemia (Fanconi's Anemia) 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 10/2017
1	Submandibular Gland Neoplasms 01/2016
1	Carcinogenesis 03/2015
1	Carcinoma (Carcinomatosis) 02/2014
1	Tremor (Tremors) 11/2003

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2018
2	Circulating Tumor DNAIBA 04/2024 - 08/2023
2	Cetuximab (Erbitux)FDA Link 01/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 05/2021
2	CytokinesIBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2017
2	Aldehyde DehydrogenaseIBA 03/2015 - 01/2012
1	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2024
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 05/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2023
1	cisatracurium (Nimbex)FDA Link 01/2023
1	pembrolizumabIBA 01/2023
1	SugammadexIBA 01/2023
1	Rocuronium (Zemuron)FDA LinkGeneric 01/2023
1	NivolumabIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	InterferonsIBA 01/2023
1	Vecuronium Bromide (Vecuronium)FDA LinkGeneric 01/2023
1	CholesterolIBA 01/2022
1	LigandsIBA 01/2021
1	Interferon Type IIBA 01/2021
1	Dental Implants (Dental Implant)IBA 01/2021
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2021
1	AerosolsIBA 01/2021
1	Coloring Agents (Dyes)IBA 05/2019
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 05/2019
1	antineoplaston A10 (A 10)IBA 05/2018
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 05/2018
1	DNA Repair EnzymesIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	AntibodiesIBA 01/2016
1	sphingosine kinaseIBA 02/2011
1	Small Interfering RNA (siRNA)IBA 02/2011
1	SmokeIBA 10/2006
1	Messenger RNA (mRNA)IBA 11/2003

Therapy/Procedure

12	Therapeutics 07/2023 - 10/2006
10	Laryngectomy 05/2024 - 01/2017
6	Radiotherapy 01/2023 - 02/2011
6	Tracheostomy 11/2022 - 01/2017
5	Chemoradiotherapy 07/2023 - 02/2014
4	Neck Dissection (Radical Neck Dissection) 11/2023 - 10/2017
3	Drug Therapy (Chemotherapy) 03/2022 - 07/2012
2	Tertiary Prevention 11/2023 - 05/2021
2	Free Tissue Flaps 11/2023 - 10/2021
2	Induction Chemotherapy 03/2022 - 01/2022
1	Perioperative Care 11/2023
1	Patient Readmission 11/2023
1	Length of Stay 11/2023
1	Aftercare (After-Treatment) 01/2023
1	Anesthesia 01/2023
1	General Anesthesia 01/2023
1	Terminal Care (Care, Terminal) 01/2023
1	Artificial Respiration (Mechanical Ventilation) 07/2021
1	Mechanical Ventilators (Ventilator) 07/2021
1	Immunotherapy 01/2021
1	Precision Medicine 01/2021
1	Personal Protective Equipment 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2016